Lilly Buys Cholesterol Assets
Eli Lilly expands its cholesterol treatment portfolio through acquisitions. The move follows positive trial results for its cholesterol shot.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.